Imaging biomarkers for cardiometabolic risk stratification in metabolic dysfunction-associated steatotic liver disease: incremental value of coronary artery calcification, epicardial adipose tissue, controlled attenuation parameter, and liver stiffness measurement beyond clinical scores

British Journal of Radiology · Published 2026-05-15 · DOI 10.1093/bjr/tqag112

Authors (5)

Jiaxin Zhong, Huifen He, Yiwei Zhao, Jiao Zeng, Zixin Cai

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Zhong, J., He, H., Zhao, Y., et al. (2026). Imaging biomarkers for cardiometabolic risk stratification in metabolic dysfunction-associated steatotic liver disease: incremental value of coronary artery calcification, epicardial adipose tissue, controlled attenuation parameter, and liver stiffness measurement beyond clinical scores. British Journal of Radiology. https://doi.org/10.1093/bjr/tqag112

Related articles